Opinion: Drug prices may drop under Medicare reform plans – But it could come at great cost to patients' health

Department of Health and Human Services Secretary Alex Azar recently proposed sweeping reforms to Medicare. He hopes the changes will reduce the price of many cancer drugs and other advanced therapies by 30 percent. The proposal may accomplish that goal – but only at great costs to patients' health. The overhaul would stifle innovation and smother the cures of tomorrow.